As spot­light trains on bio­phar­ma di­ver­si­ty, most com­pa­nies kept their C-suites ex­act­ly the same in 2020 — re­port

4 years ago
Pharma

In an ef­fort to safe­ly de­liv­er mR­NA, Stan­ford Uni­ver­si­ty teams up with Ger­man biotech Evonik

4 years ago
Deals
Manufacturing

'No rea­son to slow down any­thing here': Cure­Vac plans to march on with Covid-19 vac­cine af­ter piv­otal fail­ure

4 years ago
Coronavirus

Biden in­vests $3B in­to an­tivi­ral de­vel­op­ment for Covid-19

4 years ago
Coronavirus

As it awaits piv­otal re­view of lead drug, Fi­bro­Gen bol­sters its ear­ly pipeline with li­cens­ing deal for galectin ...

4 years ago
Deals

Don’t hold your breath wait­ing for FDA nom­i­nee; A pri­or­i­ty re­view for an­oth­er Bris­tol My­ers part­ner

4 years ago
News Briefing

Bay­er clos­ing down San Fran­cis­co re­search hub as at­ten­tion turns to Berke­ley plan

4 years ago
Pharma

Covid-19 man­u­fac­tur­ing roundup: As the US gov­ern­ment bags an­oth­er 100M dos­es of Mod­er­na shot, the biotech is chip­ping ...

4 years ago
Coronavirus
Manufacturing

In a move to boost its nat­ur­al killer can­di­dates, Sen­ti Bio will build out its own San Fran­cis­co man­u­fac­tur­ing ...

4 years ago
Cell/Gene Tx
Manufacturing

Vi­ral man­u­fac­tur­er Viba­log­ics plots out ex­pan­sion at Ger­man site as US growth plans are un­der­way

4 years ago
Outsourcing
Manufacturing

Dana­her strikes deal to buy boom­ing next-gen man­u­fac­tur­er Alde­vron for $9.6B

4 years ago
Deals
Manufacturing

Sid Mukher­jee's Vor adds clin­i­cal man­u­fac­tur­ing fa­cil­i­ty at ex­ist­ing Boston-area site, beef­ing up for a com­mer­cial ...

4 years ago
R&D
Manufacturing

A re­place­ment for read­ing glass­es? An RA, Ver­sant-backed start­up thinks its eye­drops could solve far­sight­ed­ness

4 years ago
Financing
Startups

Covid-19 roundup: Pfiz­er says Xel­janz re­duced death and lung fail­ure in hos­pi­tal­ized Covid-19 pa­tients; US halts ...

4 years ago
Coronavirus

Blue­print Med­i­cines nabs 4th ap­proval in bid to­ward prof­itabil­i­ty

4 years ago
R&D

No­var­tis sets the tone for the ra­dio­phar­ma push with a prized ac­qui­si­tion win­ning break­through ther­a­py des­ig­na­tion

4 years ago
FDA+

Med­ic­aid com­mis­sion to Con­gress: In­crease re­bates for ac­cel­er­at­ed ap­proval drugs

4 years ago
Pharma
FDA+

Rick Klaus­ner's crew of T cell spe­cial­ists wraps $425M IPO, hit­ting Nas­daq along­side Verve, Mol­e­c­u­lar Part­ners

4 years ago
Financing

A UK biotech looks to bring al­liance be­tween GSK, J&J, As­traZeneca, and top uni­ver­si­ties state­side with its first ...

4 years ago
Financing

Cure­Vac blames vari­ants as a close­ly-watched Covid vac­cine goes down in flames, fail­ing piv­otal study with woe­ful ...

4 years ago
R&D

Days af­ter con­tro­ver­sy greet­ed Bio­gen's block­buster Alzheimer's OK, the big biotech con­cedes a set­back on the tau ...

4 years ago
R&D

No­vo Nordisk to re­search oral obe­si­ty treat­ment; Dana-Far­ber taps in­to Har­bour Bio­Med's mice plat­form in mul­ti­year ...

4 years ago
News Briefing

The Ko­dak in­sid­er trad­ing dra­ma con­tin­ues as CEO set for ques­tion­ing in NY state probe

4 years ago
People
Pharma

An Is­raeli biotech is look­ing to make its name in the jam-packed CD47 space. Is bi­func­tion­al­i­ty the an­swer?

4 years ago
Financing
First page Previous page 679680681682683684685 Next page Last page
A service from the Financial Times